<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347511">
  <stage>Registered</stage>
  <submitdate>21/09/2011</submitdate>
  <approvaldate>22/09/2011</approvaldate>
  <actrnumber>ACTRN12611001018909</actrnumber>
  <trial_identification>
    <studytitle>Tramadol administration in the critically ill</studytitle>
    <scientifictitle>Pharmacokinetics of Subcutaneous Tramadol in Intensive Care Unit (ICU) step down patients</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intensive Care Unit (ICU) Step Down patients who require patient controlled analgesia (PCA) Fentanyl as part of their management after trauma or surgery.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Tramadol Hydrochloride 50mg one injection only on study day.  Administered over 1 minute subcutaneously</interventions>
    <comparator>None</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Rate of absorption of Tramadol administered subcutaneously as indicated by serum concentration of racemic tramadol and urine concentrations of tramadol and its  M1 (o-demethyltramadol) and M2 (mono-N-demethyltramadol) metabolites</outcome>
      <timepoint>t=0(pre-dose), 2, 5, 10, 15, 30, 60, 90, 120, 180, 240, 300, 360, 480min and 24h after injection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time to peak of Tramadol administered subcutaneously as indicated by serum concentration of racemic tramadol and urine concentrations of tramadol and its  M1 (o-demethyltramadol) and M2 (mono-N-demethyltramadol) metabolites</outcome>
      <timepoint>t=0(pre-dose), 2, 5, 10, 15, 30, 60, 90, 120, 180, 240, 300, 360, 480min and 24h after injection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ICU Step down patients who require patient controlled analgesia(PCA) Fentanyl as part of their management after trauma or surgery
Adequate venous access to collect blood</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindication and/or allergy to the use of Tramadol or Fentanyl
Significant hepatic impairment (3 times the limit of upper range Liver Function Test)
Chronic use of central nervous system depressants
Drugs that inhibit CYP2D6 activity
History of epilepsy
Renal dysfunction (creatinine clearance of less than or equal to 75ml/min)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>1. Informed consent obtained
2. Administration of subcutaneous Tramadol in all subjects (15 subjects)</concealment>
    <sequence>Nonrandomised trial</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>24/04/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Guy Ludbrook</primarysponsorname>
    <primarysponsoraddress>Discipline of Acute Care Medicine
University of Adelaide
North Terrace
Adelaide 
South Australia 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Adelaide</fundingname>
      <fundingaddress>Discipline of Acute Care Medicine
North Terrace
Adelaide
South Australia 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Associate Professor Marianne Chapman</sponsorname>
      <sponsoraddress>Intensive Care Unit
Royal Adelaide Hospital
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Associate Professor Pamela Macintyre</sponsorname>
      <sponsoraddress>Department of Anaesthesia
Royal Adelaide Hospital
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Krishnaswamy Sundararajan</sponsorname>
      <sponsoraddress>Intensive Care Unit
Royal Adelaide Hospital
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Jennifer Ong</sponsorname>
      <sponsoraddress>University of Adelaide
Discipline of Acute Care Medicine
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Richard Upton</sponsorname>
      <sponsoraddress>Department of Anaesthesia
Royal Adelaide Hospital
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Stephanie O'Connor</sponsorname>
      <sponsoraddress>Intensive Care Unit
Royal Adelaide Hospital
North Terrace
Adelaide 
South Australia 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study enabled dosing intervals, peak plasma concentration and rate of absorption of subcutaneous tramadol to be determined in Intensive Care Step Down Unit patients. It also permitted pharmacokinetic comparison with other subcutaneous opioids and assist in clinical decision-making about optimal opioid dosing regimens for moderate to severe acute pain.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress>Royal Adelaide Hospital 
North Terrace
Adelaide
South Australia 5000</ethicaddress>
      <ethicapprovaldate>10/08/2009</ethicapprovaldate>
      <hrec>090719</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jennifer Ong</name>
      <address>Deiscipline of Acute Care Medicine
Univerisity of Adelaide
North Terrace
Adelaide
South Australia 5000</address>
      <phone>+61 8 8303 5909</phone>
      <fax />
      <email>jennifer.ong@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Krishnaswamy Sundararajan</name>
      <address>Intensive Care Unit
Royal Adelaide Hospital 
North Terrace
Adelaide
South Australia 5000</address>
      <phone>+61 8 8222 4624</phone>
      <fax />
      <email>Krishnaswamy.Sundararajan@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Stephanie O'Connor</name>
      <address>Intensive Care Unit
Royal Adelaide Hospital 
North Terrace
Adelaide
South Australia 5000</address>
      <phone>+61 8 8222 4624</phone>
      <fax />
      <email>stephanie.oconnor@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>